Since ancient times, fake drugs have been on the market in Chinese society. However, during the Ming-Qing Dynasty, this problem intensified as the size of the pharmaceutical market grew, the collection and distribution structure of pharmaceutical products became increasingly complex, and the phenomenon of separation between the prescription and distribution of drugs advanced. Additionally, the government did not manage the manufacturing or quality of drugs and there was no law or institution designed to solve the problem of fake drugs. Furthermore, social opinion also criticized the widespread problem of fake drugs, and patients and doctors had to rely on various pharmacognostic books and medical knowledge to find reliable drugs in the drug market. Meanwhile, as merchants participated and invested commercial capital in the pharmaceutical industry, large reputable pharmacies began to emerge in large cities and produced drugs. With the commercialization of the pharmaceutical market, the public gained interest in drugs and consumed drugs produced by these pharmacies. Moreover, there were frequent problems in the market as fake drugs imitating popular drugs were distributed and the names of famous pharmacies were stolen. Although fake drugs were a universal social problem, the Qing government was reluctant to strictly control them tried to solve this issue by enforcing banning and punishment through local governments. Prominent pharmacies filed several lawsuits against the government over the theft of fake drugs and drug names. They also advertised the legitimacy and authenticity of drugstore to the public and customers. Doctors and merchants responded to the problem of fake drugs by following occupational morality, developing drug discrimination, cracking down on organizational discipline, filing complaints with government offices, and advertising their authenticity. However, the fake medicines did not easily disappear despite such a response, as there was no state control or legislation. Evidently, the pharmaceutical market was already highly commercialized and its structure were complex. Moreover, the financial benefits of fake drugs, competition in the pharmaceutical market, and public demand for drugs with similar effects at low prices also affected the popularity of fake drugs. Hence, the distribution of fake medicine in the Qing society can be seen as a phenomenon of separation between the prescription and distribution of drugs, commercialization and consumption of drugs, and competition on the medical market.
...MoreSimilar Citations
Article
Jihee Choi;
(2019)
Social Perceptions of Quack in Qing Dynasty and Its Transformation in the Late Qing Period
(/isis/citation/CBB623216066/)
Article
Eugenia Lean;
(2018)
Making the Chinese Copycat: Trademarks and Recipes in Early Twentieth-Century Global Science and Capitalism
(/isis/citation/CBB887414849/)
Article
Natassia F. Brenman;
Richard Milne;
(May 2022)
“Ready for What?”: Timing and Speculation in Alzheimer’s Disease Drug Development
(/isis/citation/CBB016946522/)
Article
Giulia Bovone;
(2022)
Una rassegna di pubblicità di prodotti farmaceutici al limite tra scienza e ciarlataneria. Fine XIX secolo – Inizi XX secolo
(/isis/citation/CBB745169341/)
Book
Gabriel, Joseph M.;
(2014)
Medical Monopoly: Intellectual Property Rights and the Origins of the Modern Pharmaceutical Industry
(/isis/citation/CBB001422032/)
Article
Gabriel, Joseph M.;
(2009)
A Thing Patented Is a Thing Divulged: Francis E. Stewart, George S. Davis, and the Legitimization of Intellectual Property Rights in Pharmaceutical Manufacturing, 1879--1911
(/isis/citation/CBB000930500/)
Article
Javier Lezaun;
Catherine M. Montgomery;
(2015)
The Pharmaceutical Commons Sharing and Exclusion in Global Health Drug Development
(/isis/citation/CBB301150395/)
Article
Osseo-Asare, Abena Dove;
(2008)
Bioprospecting and Resistance: Transforming Poisoned Arrows into Strophantin Pills in Colonial Gold Coast, 1885--1922
(/isis/citation/CBB000930666/)
Book
Myles W. Jackson;
(2015)
The Genealogy of a Gene: Patents, HIV/AIDS, and Race
(/isis/citation/CBB193037134/)
Article
Javier Lezaun;
Catherine Montgomery;
(January 2015)
The Pharmaceutical Commons: Sharing and Exclusion in Global Health Drug Development
(/isis/citation/CBB051732021/)
Chapter
Hayden, Cori;
(2011)
No Patent, No Generic: Pharmaceutical Access and the Politics of the Copy
(/isis/citation/CBB001221561/)
Article
Greene, Jeremy A.;
(2013)
The Materiality of the Brand: Form, Function, and the Pharmaceutical Trademark
(/isis/citation/CBB001320757/)
Book
Biagioli, Mario;
Jaszi, Peter;
Woodmansee, Martha;
(2011)
Making and Unmaking Intellectual Property: Creative Production in Legal and Cultural Perspective
(/isis/citation/CBB001221432/)
Book
Dudley, Leonard;
(2012)
Mothers of Innovation: How Expanding Social Networks Gave Birth to the Industrial Revolution
(/isis/citation/CBB001201315/)
Article
Zhang, Fang;
(2015)
Changes in and Influence of the Images in the Bencao Yuanshi
(/isis/citation/CBB543046519/)
Chapter
Benjamin A. Elman;
(2010)
The Investigation of Things (gewu 格 物), Natural Studies (gezhixue 格 致 學), and Evidental Studies (kaozhengxue 考 證 學) Gewu in Late Imperial China, 1600-1800
(/isis/citation/CBB533601903/)
Article
Sun, Chengsheng;
(2014)
The Dissemination and Influence of Three Regions Theory in Late Ming and Early Qing China
(/isis/citation/CBB911929092/)
Article
Huiyi Wu;
Alexander Statman;
Mario Cams;
(2018)
Focus Introduction: Displacing Jesuit Science in Qing China
(/isis/citation/CBB672043931/)
Article
Yuda Yang;
Nanny Kim;
(2019)
Texts and Technologies in Chinese Silver Metallurgy, Twelfth to Nineteenth Centuries
(/isis/citation/CBB305546264/)
Article
Mario Cams;
(2018)
Blurring the Boundaries: Integrating Techniques of Land Surveying on the Qing’s Mongolian Frontier
(/isis/citation/CBB111379837/)
Be the first to comment!